What drugs does TONIX make?

TONIX has 1 FDA-approved drugs including TONMYA.

What therapeutic areas does TONIX focus on?

TONIX focuses primarily on Neurology and Infectious Disease.

← Back

Data updated: Mar 10, 2026

TONIX

NeurologyInfectious Disease

Pharma

TONIX is a pharmaceutical company focused on Neurology, Infectious Disease. Key products include TONMYA.

2025

Since

Drugs

Trials

Approved (2yr)

Key Drugs

TONMYA

cyclobenzaprine hydrochloride

5-HT2A 1 indications · 2025

Recent Activity

TONMYA 2025-08-15

Type 3 - New Dosage Form

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%

0 drugs Phase 2: 1

Infectious Disease 50%

0 drugs Phase 2: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

AbbVie big-pharma

Neurology, Infectious Disease

GSK big-pharma

Infectious Disease, Neurology

Bristol-Myers Squibb big-pharma

Infectious Disease, Neurology

GE HEALTHCARE specialty

Infectious Disease, Neurology

Novo Nordisk big-pharma

Infectious Disease, Neurology

TONIX

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info